When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves’ disease be discontinued?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://link.springer.com/content/pdf/10.1007/s12020-019-01987-w.pdf
Reference48 articles.
1. D.S. Ross, H.B. Burch, D.S. Cooper, M.C. Greenlee, P. Laurberg, A.L. Maia, S.A. Rivkees, M. Samuels, J.A. Sosa, M.N. Stan, 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26(10), 1343–1421 (2016)
2. J.P. Brito, S. Schilz, N. Singh Ospina, R. Rodriguez-Gutierrez, S. Maraka, L.R. Sangaralingham, V.M. Montori, Antithyroid drugs—the most common treatment for Graves’ disease in the United States: a nationwide population-based study. Thyroid 26(8), 1144–1145 (2016)
3. E. Mohlin, H.F. Nyström, M. Eliasson, Long-term prognosis after medical treatment of Graves’ disease in a northern Swedish population 2000-2010. Eur. J. Endocrinol. 170, 419–427 (2013)
4. H.B. Burch, K.D. Burman, D.S. Cooper, A 2011 survey of clinical practice patterns in the management of Graves’ disease. J. Clin. Endocrinol. Metab. 97(12), 4549–4558 (2012)
5. D. Villagelin, J.H. Romaldini, R.B. Santos, A.B. Milkos, L.S. Ward, Outcomes in relapsed Graves’ disease patients following radioiodine or prolonged low dose of methimazole treatment. Thyroid 25(12), 1282–1290 (2015)
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of Anti-Thyroid Medications in Patients with Graves’ Disease;BMC Endocrine Disorders;2024-09-06
2. Dynamic Risk Model for the Medical Treatment of Graves’ Hyperthyroidism according to Treatment Duration;Endocrinology and Metabolism;2024-08-31
3. Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status;Thyroid®;2023-09-01
4. Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort;European Thyroid Journal;2023-02-24
5. Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism;Archives of Endocrinology and Metabolism;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3